Research Analysts Offer Predictions for Centene Q3 Earnings

Centene Co. (NYSE:CNC) – Equities researchers at Zacks Research lowered their Q3 2025 earnings per share estimates for shares of Centene in a research report issued on Tuesday, June 10th. Zacks Research analyst K. Dey now expects that the company will post earnings per share of $1.53 for the quarter, down from their previous estimate of $1.54. The consensus estimate for Centene’s current full-year earnings is $6.86 per share. Zacks Research also issued estimates for Centene’s Q2 2026 earnings at $2.13 EPS and Q3 2026 earnings at $1.61 EPS.

Other research analysts have also issued research reports about the company. Morgan Stanley initiated coverage on Centene in a research report on Monday. They set an “overweight” rating and a $70.00 price objective for the company. Barclays restated an “equal weight” rating and set a $65.00 price target (down previously from $84.00) on shares of Centene in a research report on Monday, June 2nd. Guggenheim reissued a “neutral” rating on shares of Centene in a research note on Tuesday, April 29th. Jefferies Financial Group dropped their price target on shares of Centene from $64.00 to $61.00 and set a “hold” rating on the stock in a research note on Tuesday, April 29th. Finally, Wall Street Zen downgraded Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, April 28th. Seven research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $77.71.

Centene Stock Performance

Shares of CNC stock opened at $55.39 on Thursday. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. The business has a 50 day moving average of $59.43 and a two-hundred day moving average of $59.95. The company has a market cap of $27.56 billion, a P/E ratio of 8.88, a PEG ratio of 0.80 and a beta of 0.45. Centene has a 52 week low of $54.01 and a 52 week high of $80.59.

Centene (NYSE:CNC) last released its quarterly earnings data on Friday, April 25th. The company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.52 by $0.38. Centene had a net margin of 2.03% and a return on equity of 13.85%. The firm had revenue of $46.62 billion during the quarter, compared to the consensus estimate of $43.16 billion. During the same quarter in the previous year, the company posted $2.26 earnings per share. The firm’s revenue was up 15.4% on a year-over-year basis.

Hedge Funds Weigh In On Centene

Several large investors have recently made changes to their positions in CNC. Capital Advisors Ltd. LLC boosted its holdings in Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after buying an additional 177 shares in the last quarter. Pinney & Scofield Inc. bought a new stake in shares of Centene during the 4th quarter worth $25,000. Hurley Capital LLC acquired a new position in shares of Centene in the 4th quarter worth $26,000. Ameriflex Group Inc. acquired a new stake in shares of Centene during the fourth quarter worth $26,000. Finally, Quarry LP purchased a new stake in shares of Centene during the first quarter valued at $26,000. Institutional investors own 93.63% of the company’s stock.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.